Researchers have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease — a finding that could reverse long-standing clinical practice.
Researchers have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease — a finding that could reverse long-standing clinical practice.